Staidson (Beijing) BioPharmaceuticals Co Ltd Sustainability Reports
The company engages in the research, development, production, and marketing of biopharmaceutical products, including protein drugs, gene drugs, and chemical drugs. Its therapeutic focus includes treatments for infectious diseases, neuromuscular disorders, gastrointestinal conditions, and autoimmune diseases.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001V07JJ3
1 reports from 2024 to 2024